Key highlights from Supriya Lifescience Ltd (SUPRIYA) Q3 FY23 Earnings Concall Management Update: [00:04:00] SUPRIYA said its primary focus remains on expanding
Supriya Lifescience Ltd Q3 FY23 Earnings Conference Call Insights
Categories
Health Care
The Revival of Amrutanjan Healthcare Limited
Amrutanjan’s flagship yellow headache balm is possibly its most successful product. It is also among the first products that the company launched.
Orchid Pharma Ltd Q3 FY23 Earnings Conference Call Insights
Key highlights from Orchid Pharma Ltd (ORCHPHARMA) Q3 FY23 Earnings Concall Q&A Highlights: [00:04:43] Himanshu Upadhyay from o3 Capital asked what changed
Apollo Hospitals Enterprise Limited Q3 FY23 Earnings Conference Call Insights
Key highlights from Apollo Hospitals Enterprise Limited (APOLLOHOSP) Q3 FY23 Earnings Concall Management Update: [00:02:04] APOLLOHOSP said it had a good 3Q23,
Sun Pharma Advanced Research Q3FY23 Earnings
(SPARC) Sun Pharma Advanced Research Company Limited conducts pharmaceutical product research and development (R&D). Financial Results: After nine consecutive quarters of losses,
Earnings | Dr Lal Path Labs Ltd (NSE:LALPATHLAB): Q3FY23 Results Out; Total Income fell 2% YoY
Dr Lal Path Labs Ltd (NSE:LALPATHLAB) is a leading diagnostic services provider in India. The company was founded in 1949 by Dr.
Shilpa Medicare Limited Q3FY23 Earnings
With cutting-edge technology, Shilpa Medicare is in the business of manufacturing high-quality Active Pharmaceutical Ingredients, Intermediates, Formulations, Novel Drug delivery system, Peptides,
Earnings | Dr. Reddy’s Laboratories Ltd. (NSE:DRREDDY): Q3FY23 Results Out; Total Income rise 27% YoY
Dr. Reddy's Laboratories Ltd. (NSE:DRREDDY) is a multinational pharmaceutical company based in Hyderabad, India. The company was founded in 1984 and has
Suven pharmaceuticals Q3FY23 net profit drops by 33 percent
The company has reported total income of INR 366.78 crores during the period ended December 31, 2022 as compared to INR 456.27
Sanofi India Limited Q3FY23 Earnings Story
Sanofi India primarily deals with the Manufacture and sale of pharmaceutical products. Financial Results: The company reported a decline of 2.32% YoY
Rainbow Children’s Medicare Q3FY23 Earnings
An Indian hospital network with many specialties in paediatrics, obstetrics, and gynaecology is run by Rainbow Children's Medicare Limited. The business provides
Earnings | Brooks Laboratories Ltd (NSE: BROOKS): Q3FY23 Results Out; Total Income fell 20% YoY
Brooks Laboratories Ltd (NSE: BROOKS) is a pharmaceutical company based in India. The company offers a range of products that include dry
Torrent pharma Q3FY23 net profit rises by 14 percent
Torrent Pharma reported that its consolidated net profit increased by 14 per cent to INR 283 crore in the third quarter ended
Procter & Gamble Health Q2FY23 Earnings Story
Procter & Gamble Health Ltd. primarily deals with both manufacturing and marketing various chemicals and pharmaceuticals. Financial Results: Procter & Gamble Health
Procter & Gamble Hygiene & Health Care Q2FY23 Earnings Story
In the femcare and healthcare industries, Procter & Gamble Hygiene and Health Care Ltd manufactures and sells branded packaged FMCG. Its portfolio
Vijaya Diagnostic Q3FY23 net profit drops by 35 percent
Vijaya Diagnostic reported total income of INR 116.67 crores during the period ended December 31, 2022 as compared to INR 113.97 crores
IPCA Laboratories Ltd Q3 FY23 Earnings Conference Call Insights
Key highlights from IPCA Laboratories Ltd (IPCALAB) Q3 FY23 Earnings Concall Q&A Highlights: [00:11:51] Kunal Dhamesha of Macquarie asked if IPCALAB is
Earnings | Aurobindo Pharma Ltd. (NSE:AUROPHARMA): Q3FY23 Results Out; Total Income rise 7% YoY
Aurobindo Pharma Ltd. (NSE:AUROPHARMA) is a global pharmaceutical company headquartered in India. The company produces and sells a wide range of generic
Earnings | AstraZeneca Pharma India Ltd. (NSE:ASTRAZEN): Q3FY23 Results Out; Total Income rise 25% YoY
AstraZeneca Pharma India Ltd. (NSE:ASTRAZEN) is a leading biopharmaceutical company that operates in India. The company manufactures and markets prescription drugs for
Earnings | Aster DM Healthcare Ltd (NSE: ASTERDM): Q3FY23 Results Out; Total Income rise 20% YoY
Aster DM Healthcare Ltd (NSE: ASTERDM) is a multinational healthcare company that operates hospitals, medical centers, diagnostic centers, laboratories, and pharmacies in
Panacea Biotec Limited Q3FY23 Earnings Story
With very few suppliers in the vaccination market, this creates an opportunity for India’s leading vaccine developer – Panacea Biotec Limited. Panacea